期刊文献+

塞来昔布有关物质的HPLC法测定 被引量:2

Determination of the Related Substances in Celecoxib by HPLC
原文传递
导出
摘要 建立了高效液相色谱法测定塞来昔布原料药中的有关物质。采用Zorbax SB-苯基柱,流动相为乙腈∶0.02 mol/L磷酸二氢钾缓冲液(用磷酸调至p H 3.0)(35∶65),检测波长215 nm。塞来昔布及其4个有关物质在0.1~10μg/ml范围内线性关系良好;有关物质回收率为95.7%~99.3%,RSD为1.23%~1.63%;各有关物质的检测限为0.01μg/ml,定量限为0.03μg/ml。本方法简便准确、重现性好、精密度高,可有效检测塞来昔布中的有关物质,为本品的质量控制提供参考。 An HPLC method was established for the determination of the related substances in celecoxib. The separation was performed on a Zorbax SB-Phenyl column, with the mobile phase of acetonitrile∶0.02 mol/L potassium dihydrogen phosphate buffer(adjusted to p H 3.0 with phosphoric acid)(35∶65), at the detection wavelength of 215 nm. It was linear for celecoxib and its related substances in the range of 0.1-10 μg/ml. The recoveries for the related substances were 95.7%-99.3%, with RSDs of 1.23%-1.63%. The detection limits of the related substances were 0.01 μg/ml, and the quantitation limits were 0.03 μg/ml. The method is simple, accurate, reproducible, and suitable for the determination of related substances in celecoxib, which provides a reliable method for the quality control of celccoxib.
作者 蒋振东 杨琳 卢巍 JIANG Zhendong;YANG Lin;LU Wei(Zunyi Medical College Zhuhai Campus,Zhuhai 519041)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2018年第9期1295-1299,共5页 Chinese Journal of Pharmaceuticals
基金 国家自然科学基金项目(81760416) 贵州省科技计划项目(黔科合基础[2017]1226)
关键词 塞来昔布 有关物质 高效液相色谱 含量测定 celecoxib related substance HPLC content determination
  • 相关文献

参考文献7

二级参考文献59

  • 1刘世海,郑海萍,何藻鹏,黄继辉.玻璃酸钠联合塞来昔布治疗膝关节骨性关节炎的临床疗效观察[J].黑龙江医学,2013,37(10):943-945. 被引量:7
  • 2刘国辉,张玉,杨述华.鹿瓜多肽临床应用的疗效观察及分析[J].中国医院药学杂志,2004,24(8):490-491. 被引量:41
  • 3曾庆橗,刘亚非,赵忠建.α,α,α-三氟苯乙酮的合成及其应用[J].中国医药工业杂志,1994,25(10):463-463. 被引量:1
  • 4Mckenna F, Borenstein D. Celecoxib versus dicloenac in the management of osteoarthritis of the knee [ J]. Scand J Rheumatol,2001,11 (1):11 -18.
  • 5CHAMPION G D, FENG P H, AZUMA T, et al. NSAIDs induced gastrointestinal damage[J], Drugs, 1997, 53(1): 6-19.
  • 6GRAUL A, AERTEL A M, CASTANER J. Celecoxib: anti-inflammatory cyclooxygenase-2 inhibitor[J], Drugs Fut,1997, 22(7):711-714.
  • 7ABDELLATIF K R, CHOWDHURY M A, DONG Y, et al.Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies[J]. Bioorg Med Chem,2008, 16(22): 9694-9698.
  • 8PENNING T D, TALLEY J J, BERTENSHAW S R, et al. Synthesis and biological evaluation of the 1,5-diaryl -pyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)- -1H-pyrazol-1-yl] benzenesulfonamide (SC-58635, Celecoxib)[J]. J Med Chem,. 1997, 40(9):1347-1365.
  • 9SREENIVAS R D, SRINIVASU M K, LAKSHMI N C, et al. LC separation of ortho and meta isomers of celecoxib in bulk and formulations using a chiral column[J]. J Pharm Biomed Anal, 25(2001):21-30.
  • 10NAGESWARA R R, MEENA S, RAGHURAM R A, et al. Liquid-chromatographic separation and determination of process-related impurities,including a regio-specific isomer of celecoxib on reversed-phase C18 column dynamically coated with hexamethyldisilazane[J]. Anal Sci, 2006, 22(9):1257-1260.

共引文献72

同被引文献17

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部